What does this video actually claim?
Jom explains differences between testosterone esters like cypionate, enanthate, and propionate, focusing on their release rates and injection schedules. He suggests these esters behave differently in the body and require different dosing approaches.
The video targets people considering testosterone replacement therapy or cycling. Jom discusses how ester length affects hormone levels and injection frequency. He's basically giving a primer on testosterone pharmacokinetics.
Does the science actually support these claims?
The core premise is correct. Different esters do release testosterone at different rates due to their molecular structure and lipophilicity.
Testosterone cypionate and enanthate have similar half-lives of about 4-5 days, while propionate has a much shorter half-life of roughly 0.8 days (Nieschlag et al., Andrology, 2020). This means propionate requires more frequent injections to maintain stable levels.
The pharmacokinetic differences are real and clinically relevant. A study in the Journal of Clinical Endocrinology found testosterone cypionate maintained therapeutic levels for 7-10 days post-injection, while propionate dropped below therapeutic range within 2-3 days.
What did he get wrong about injection timing?
Jom oversimplifies the injection schedules. Many clinicians now recommend more frequent dosing than he suggests, even for longer esters.
Current best practices often involve cypionate or enanthate twice weekly, not weekly. The American Urological Association guidelines note that more frequent injections reduce peak-to-trough hormone fluctuations, improving symptom control.
His propionate advice about daily injections is correct, but he doesn't mention that many people find this schedule impractical. That's why longer esters became standard despite their older introduction to medicine.
What's missing from his ester explanation?
Jom doesn't discuss how ester choice affects side effects or individual response variation. Some people do better on shorter esters despite the injection burden.
He also skips discussing testosterone undecanoate, which has a 33-day half-life and allows monthly dosing (Behre et al., European Journal of Endocrinology, 2022). This newer option is gaining traction in clinical practice.
The video lacks context about monitoring requirements. All testosterone formulations require regular blood work to check levels, hematocrit, and lipids regardless of ester type.
What should you actually know about testosterone esters?
The ester determines release speed, not testosterone potency. All deliver the same hormone once cleaved by enzymes.
Cypionate and enanthate are essentially interchangeable in clinical practice. Most insurance formularies prefer one over the other, making cost more relevant than pharmacokinetic differences between these two.
Individual response matters more than ester theory suggests. Some people feel better with stable levels from frequent injections, others prefer less frequent dosing even with more fluctuation. Work with a provider who monitors your specific response.